Headlands Technologies’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,718
Closed -$208K – 275
2026
Q2
$208K Buy
+9,718
New +$149K 0.02% 600
2026
Q1
– Sell
-55,191
Closed -$896K – 717
2025
Q4
$896K Buy
+55,191
New +$901K 0.07% 290
2024
Q1
– Sell
-1,818
Closed -$8.91K – 1220
2023
Q4
$8.91K Sell
1,818
-982
-35% -$4.48K ﹤0.01% 777
2023
Q3
$15.3K Sell
2,800
-6,732
-71% -$44.5K 0.01% 638
2023
Q2
$64K Buy
+9,532
New +$70.9K 0.02% 444

Other funds holding ADPT

Headlands Technologies's ADPT Position: Q3 2026 in Review

Headlands Technologies sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 9,718 shares — an estimated $208K sold.

Headlands Technologies first reported a position in ADPT in Q2 2023 and held it in 5 quarters. The position peaked at $896K in Q4 2025. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Headlands Technologies reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
  • Headlands Technologies sold 9,718 Adaptive Biotechnologies shares in Q3 2026, an estimated $208K.
  • Headlands Technologies first reported a position in Adaptive Biotechnologies in Q2 2023 and held it in 5 quarters.
  • Headlands Technologies's Adaptive Biotechnologies position peaked at $896K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Headlands Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.